Literature DB >> 20008773

Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.

Enrique Calvo1, F Javier Pastor, M Mar Rodríguez, Emilio Mayayo, Valentina Salas, Josep Guarro.   

Abstract

We have evaluated the efficacy of posaconazole, amphotericin B, and itraconazole in a murine model of disseminated infection by Fonsecaea monophora. Of these three antifungal drugs tested, posaconazole prolonged survival significantly and reduced the fungal load in most of the organs tested. Bioassay studies demonstrated the relationship between posaconazole levels and dose escalation in serum and brain tissue. Posaconazole may have a clinical role in the treatment of disseminated infections by F. monophora.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008773      PMCID: PMC2812182          DOI: 10.1128/AAC.01284-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Molecular ecology and pathogenic potential of Fonsecaea species.

Authors:  G S De Hoog; D Attili-Angelis; V A Vicente; A H G Gerrits Van Den Ende; F Queiroz-Telles
Journal:  Med Mycol       Date:  2004-10       Impact factor: 4.076

2.  Distribution and activity of amphotericin B in humans.

Authors:  K J Christiansen; E M Bernard; J W Gold; D Armstrong
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

3.  Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.

Authors:  Liyan Xi; Jiufeng Sun; Changming Lu; Honfang Liu; Zhi Xie; Kazutaka Fukushima; Kayoko Takizawa; Mohammad Javad Najafzadeh; G S De Hoog
Journal:  Med Mycol       Date:  2008-10-25       Impact factor: 4.076

4.  Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.

Authors:  Ricardo Negroni; Silvia Haydeé Helou; Nestor Petri; Ana María Robles; Alicia Arechavala; Mario Horacio Bianchi
Journal:  Clin Infect Dis       Date:  2004-01-13       Impact factor: 9.079

5.  Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.

Authors:  Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Med Mycol       Date:  2008-12-12       Impact factor: 4.076

6.  Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora.

Authors:  Liyan Xi; Changming Lu; Jiufeng Sun; Xiqing Li; Honfang Liu; Junmin Zhang; Zhi Xie; G S De Hoog
Journal:  Med Mycol       Date:  2008-09-15       Impact factor: 4.076

7.  Genetic diversity and species delimitation in the opportunistic genus Fonsecaea.

Authors:  M J Najafzadeh; C Gueidan; H Badali; A H G Gerrits Van Den Ende; Lian Xi; G S De Hoog
Journal:  Med Mycol       Date:  2008-12-19       Impact factor: 4.076

8.  Optimization of bioassay method for the quantitative microbiological determination of amphotericin B.

Authors:  András Fittler; Béla Kocsis; Imre Gerlinger; Lajos Botz
Journal:  Mycoses       Date:  2009-01-14       Impact factor: 4.377

9.  Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

Authors:  John R Graybill; Laura K Najvar; Elizabeth Johnson; Rosie Bocanegra; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Simplified bioassay method for measurement of flucytosine or ketoconazole.

Authors:  C A Bodet; J H Jorgensen; D J Drutz
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

View more
  13 in total

1.  Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

Authors:  S Seyedmousavi; K Samerpitak; A J M M Rijs; W J G Melchers; J W Mouton; P E Verweij; G S de Hoog
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.

Authors:  François Barde; Eliane Billaud; Lauriane Goldwirt; Catherine Horodyckid; Vincent Jullien; Fanny Lanternier; Philippe Lesprit; Lucie Limousin; Jérémie F Cohen; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 3.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.

Authors:  Enrique Calvo; F Javier Pastor; Emilio Mayayo; Pilar Hernández; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 5.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 6.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  VNI cures acute and chronic experimental Chagas disease.

Authors:  Fernando Villalta; Mark C Dobish; Pius N Nde; Yulia Y Kleshchenko; Tatiana Y Hargrove; Candice A Johnson; Michael R Waterman; Jeffrey N Johnston; Galina I Lepesheva
Journal:  J Infect Dis       Date:  2013-01-31       Impact factor: 5.226

Review 8.  CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors:  Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

Review 9.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

10.  Cladophialophora bantiana osteomyelitis in a renal transplant patient.

Authors:  Stefanie Desmet; Liesbeth Smets; Katrien Lagrou; Inge Derdelinckx; Jeroen Neyt; Johan Maertens; Raf Sciot; Philip Demaerel; Bert Bammens
Journal:  Med Mycol Case Rep       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.